These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 35253410)

  • 1. A complex systems view on the current hypotheses of epilepsy pharmacoresistance.
    Servilha-Menezes G; Garcia-Cairasco N
    Epilepsia Open; 2022 Aug; 7 Suppl 1(Suppl 1):S8-S22. PubMed ID: 35253410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments.
    Löscher W; White HS
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.
    Naimo GD; Guarnaccia M; Sprovieri T; Ungaro C; Conforti FL; Andò S; Cavallaro S
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
    Rogawski MA
    Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of drug-resistant epilepsy: A reappraisal based on epilepsy types.
    Asadi-Pooya AA; Farazdaghi M
    Acta Neurol Scand; 2022 May; 145(5):627-632. PubMed ID: 35130355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyamine Modulation of Anticonvulsant Drug Response: A Potential Mechanism Contributing to Pharmacoresistance in Chronic Epilepsy.
    Beckonert NM; Opitz T; Pitsch J; Soares da Silva P; Beck H
    J Neurosci; 2018 Jun; 38(24):5596-5605. PubMed ID: 29789377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of drug-resistant canine epilepsy.
    Potschka H; Fischer A; Löscher W; Volk HA
    Vet J; 2023; 296-297():105990. PubMed ID: 37150317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABC Transporters and Drug Resistance in Patients with Epilepsy.
    Feldmann M; Koepp M
    Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoresistance - Epidemiology, mechanisms, and impact on epilepsy treatment.
    Janmohamed M; Brodie MJ; Kwan P
    Neuropharmacology; 2020 May; 168():107790. PubMed ID: 31560910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular mechanisms of pharmacoresistance in epilepsy.
    Remy S; Beck H
    Brain; 2006 Jan; 129(Pt 1):18-35. PubMed ID: 16317026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
    Löscher W; Potschka H
    J Pharmacol Exp Ther; 2002 Apr; 301(1):7-14. PubMed ID: 11907151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the concept of drug-resistant epilepsy: A TASK1 report of the ILAE/AES Joint Translational Task Force.
    Auvin S; Galanopoulou AS; Moshé SL; Potschka H; Rocha L; Walker MC;
    Epilepsia; 2023 Nov; 64(11):2891-2908. PubMed ID: 37676719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to the special issue "Redesigning the hypotheses for drug-resistant epilepsy".
    Rocha L
    Epilepsia Open; 2022 Aug; 7 Suppl 1(Suppl 1):S6-S7. PubMed ID: 35088580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies.
    Fattorusso A; Matricardi S; Mencaroni E; Dell'Isola GB; Di Cara G; Striano P; Verrotti A
    Front Neurol; 2021; 12():674483. PubMed ID: 34239494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for a paradigm shift in the research on the epilepsies and associated neuropsychiatric comorbidities. From ancient historical knowledge to the challenge of contemporary systems complexity and emergent functions.
    Garcia-Cairasco N; Podolsky-Gondim G; Tejada J
    Epilepsy Behav; 2021 Aug; 121(Pt B):107930. PubMed ID: 33836959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects and biological bases of drug-resistant epilepsies.
    Regesta G; Tanganelli P
    Epilepsy Res; 1999 Apr; 34(2-3):109-22. PubMed ID: 10210025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.
    Löscher W; Potschka H; Sisodiya SM; Vezzani A
    Pharmacol Rev; 2020 Jul; 72(3):606-638. PubMed ID: 32540959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1873-1888. PubMed ID: 28290134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.
    Campos G; Fortuna A; Falcão A; Alves G
    Epilepsy Res; 2018 Oct; 146():63-86. PubMed ID: 30086482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population.
    D'Onofrio G; Roberti R; Riva A; Russo E; Verrotti A; Striano P; Belcastro V
    Neurotherapeutics; 2024 Apr; 21(3):e00344. PubMed ID: 38521667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.